A History of Heart Disease Prevention Innovation

We have a long history of leadership in the field of heart disease prevention. 

In 1958, Angelo Scanu, MD, described the biochemical makeup of HDL, the "good" cholesterol. Over five decades, Dr. Scanu expanded on his research into the genetics and mechanisms of lipid disorders at the University of Chicago.

Later, Michael H. Davidson, MD, was the lead researcher who discovered the dose of oat bran that lowers cholesterol levels. He also pioneered the development of statins, the leading drugs for treating high cholesterol.

Ongoing Prevention Care

Today, our Lipid Clinic works with our patients to actively manage their cholesterol and take control of their cardiovascular health. Our doctors are world renowned for their research into cholesterol and the genetics of lipid disorders. Because we know high cholesterol problems can run in families, we know that lipid care is very specialized.

Our Lipid Clinic performs tests to evaluate suspected lipid disorders. After a diagnosis is made, our physicians develop individualized treatment plans that may include diet recommendations and the use of cholesterol-lowering drugs. These recommendations are designed to lower cholesterol levels and to reduce the risk for heart disease.

Our patients are encouraged to invite family members (including children) to the clinic to undergo testing. As with many forms of heart problems, early detection is a key factor in preventing serious complications.